InvestorsHub Logo
Followers 229
Posts 14669
Boards Moderated 1
Alias Born 03/29/2014

Re: None

Monday, 06/01/2015 9:34:41 PM

Monday, June 01, 2015 9:34:41 PM

Post# of 701425
Someone earlier had posted a link to "here's a real data release on cancer immunological therapy". The test results were presented on Sunday at ASCO. And has

This is for Bristol Myers Squibb's combined trial for untreated melanoma for Ipilimumab and Nivolumab.

Here's the journal article...
http://www.nejm.org/doi/full/10.1056/NEJMoa1504030#t=articleTop

Here's how the Russian Times presented it...
‘Huge paradigm shift’: Biggest cancer breakthrough in 40 years sees tumors disappear (yes, we'd like a header like that too)
http://rt.com/news/263881-cancer-treatment-breakthrough-cure/

This article in the Russian Times is written very positively, while the Time Magazine article below is not quite as glowing in it's report...

Time
http://time.com/3902868/cancer-tumors-melanoma-ipilimumab-nivolumab/

(too bad Time didn't mention what the two combined cancer drugs are. They did, however, say in the subhead this...

However, the associated side-effects of the dual treatment are amplified




And here's is the closing rise in percentages for both BMY and NWBO...

Today's percentage of rise in price for BMY... 2.89%

Today's percentage of rise in price for NWBO... 1.90%

So not bad... I'll bet BMY had hoped for a bigger jump as well.

I just don't think the market gets it yet. I'm not sure they know what to make of immunotherapy. They hear it's the paradigm shifter in cancer... but the big news they hear too are the nasty side effects... which of course, don't happen with DCVax. :)

We gots to do some educating here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News